Emergent Biosolutions (EBS) Q1 Earnings Top Estimates

Stock Information for Emergent BioSolutions Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Emergent BioSolutions Inc.

Emergent BioSolutions Secures $62.4 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)] to Bolster U.S. Biodefense Supply
Emergent BioSolutions Announces Addition to Russell 3000® Index
Emergent BioSolutions Supports Victoria's Voice Foundation's National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies
Emergent BioSolutions to Participate in Upcoming Investor Conferences
Emergent BioSolutions Reports First Quarter 2025 Financial Results
Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health
Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025
Emergent BioSolutions Announces Stock Repurchase Program

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.